Quanticel Pharmaceuticals Overview

  • Founded
  • 2009
Founded
  • Status
  • Acquired/​Merged
  • Employees
  • 12
Employees
  • Latest Deal Type
  • M&A
  • Latest Deal Amount
  • $273M
Latest Deal Amount

Quanticel Pharmaceuticals General Information

Description

Developer of medicines for the treatment of cancer and other life-threatening diseases. The company provides a platform for single-cell genomic analysis of human cancer.

Contact Information

Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Formerly VC-backed
Primary Industry
Therapeutic Devices
Other Industries
Drug Discovery
Parent Company
Primary Office
  • 1500 Owens Street
  • Suite 500
  • San Francisco, CA 94158
  • United States
+1 (415) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Quanticel Pharmaceuticals Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Merger/Acquisition 19-Oct-2015 $273M 0000 00000 Completed Generating Revenue
1. Early Stage VC 28-Nov-2011 0000 0000 Completed Startup
To view Quanticel Pharmaceuticals’s complete valuation and funding history, request access »

Quanticel Pharmaceuticals Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of medicines for the treatment of cancer and other life-threatening diseases. The company provides a platform
Therapeutic Devices
San Francisco, CA
12 As of 2015
0000
0000 0000-00-00
000000&0 0000

00000000

am, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute iru
00000000000 0000000
San Diego, CA
000 As of 0000
00000
0000 0000-00-00
000000&0

00000000

ostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor i
0000000000000
Gaithersburg, MD
00 As of 0000
00000
0000 0000-00-00
00000000 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Quanticel Pharmaceuticals Competitors (25)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Prometheus Laboratories Formerly VC-backed San Diego, CA 000 00000 000000&0
000000000 Formerly VC-backed Gaithersburg, MD 00 00000 00000000 00000
0000 000000 Formerly PE-Backed Vancouver, Canada 00 00000 00000000 00000
00000000 0000 0000 Formerly VC-backed Bannockburn, IL 0000 00000 000000&0 00000
00000 Formerly VC-backed Cambridge, MA 000 00000 000000&0
You’re viewing 5 of 25 competitors. Get the full list »

Quanticel Pharmaceuticals Executive Team (4)

Name Title Board Seat Contact Info
Stephen Kaldor Ph.D Chief Executive Officer and President
Stephen Quake Ph.D Co-Founder
Samuel Levy Ph.D Vice President of Genomic Sciences
You’re viewing 3 of 4 executive team members. Get the full list »

Quanticel Pharmaceuticals Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Quanticel Pharmaceuticals Former Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Versant Ventures Venture Capital Minority 000 0000 000000 0
To view Quanticel Pharmaceuticals’s complete investors history, request access »